Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Tranexamic Acid May Not Improve Neurologic Outcomes in Patients With TBI

Key clinical point: Early administration of tranexamic acid after TBI does not improve neurologic outcome at 6 months.

Major finding: Patients with TBI and ICH who received a 2-g bolus of tranexamic acid had a 50% lower rate of mortality.

Study details: A multicenter, prehospital trial that enrolled 1,063 patients with moderate to severe TBI.

Citation:

REPORTING FROM AAN 2019